Maria Abbracchio
Maria Pia Abbracchio | |
|---|---|
| Born | Milan, Italy |
| Occupation | Pharmacologist |
| Years active | 1979–present |
| Employer | University of Milan |
| Known for | Research on purinergic receptors and discovery of GPR17 |
| Awards | Order of Merit of the Italian Republic (2014) |
Maria Pia Abbracchio is a distinguished Italian pharmacologist whose expertise lies in examining the biochemical impacts of pharmaceuticals at the cellular scale. Since 2006, she has been frequently recognized by Thomson Reuters as one of the most extensively cited researchers. Her notable contributions include pioneering studies on purinergic receptors and the discovery of GPR17. In acknowledgement of her scientific excellence, she was honored with the Order of Merit of the Italian Republic in 2014.
Biography
Originating from Milan, Abbracchio completed her master's degree in pharmacy in 1979, followed by advanced training at the University of Texas Health Science Center at Houston between 1980 and 1981. She further specialized in toxicology at the University of Milan in 1984, earned a PhD in Experimental Medicine in Rome by 1988, and pursued postdoctoral research at University College London during 1992–1993.
In 1994, she partnered with Professor Geoffrey Burnstock, a leading figure in purinergic receptor research, and established the Purine Club—an international scientific organization dedicated to studying the pathophysiology of purinergic signaling.
From 2003 onward, Abbracchio has directed multidisciplinary research groups to foster scientific advancements both nationally and internationally. Her 2006 presentations featured innovative approaches employing biochemical agents to prevent neurological damage following stroke events, emphasizing the significance of G-protein-coupled receptors (GPCRs) in cellular control mechanisms.
Her investigations combine diverse scientific fields to analyze drug interactions with GPCRs implicated in neurodegenerative disorders such as Parkinson's, Alzheimer's, and multiple sclerosis, alongside cardiovascular diseases including stroke. A key achievement is her characterization of GPR17, which revealed its capacity to mitigate cerebral inflammation and improve cognitive performance.
Currently, Abbracchio serves as a full professor of pharmacology at the University of Milan, where she leads a research group consisting of twelve members within the university’s Research Observatory. She has published nearly 150 scholarly articles and remains highly esteemed for her significant influence on pharmacological research.